Long-Term Treatment with Extended-Release Carbidopa–Levodopa (IPX066) in Early and Advanced Parkinson’s Disease: A 9-Month Open-Label Extension Trial
Crossref DOI link: https://doi.org/10.1007/s40263-015-0242-2
Published Online: 2015-04-17
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Waters, Cheryl H.
Nausieda, Paul
Dzyak, Lyudmila
Spiegel, Joerg
Rudzinska, Monika
Silver, Dee E.
Tsurkalenko, Elena S.
Kell, Sherron
Hsu, Ann
Khanna, Sarita
Gupta, Suneel
License valid from 2015-04-01